Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning
Donation after circulatory death (DCD) offers a potential additional source of cardiac allografts. We used a porcine asphyxia model to evaluate viability of DCD hearts subjected to warm ischemic times (WIT) of 20–40 min prior to flushing with Celsior (C) solution. We then assessed potential benefits of supplementing C with erythropoietin, glyceryl trinitrate and zoniporide (Cs), a combination that we have shown previously to activate ischemic postconditioning pathways. Hearts flushed with C/Cs were assessed for functional, biochemical and metabolic recovery on an ex vivo working heart apparatus. Hearts exposed to 20-min WIT showed full recovery of functional and metabolic profiles compared with control hearts (no WIT). Hearts subjected to 30- or 40-min WIT prior to C solution showed partial and no recovery, respectively. Hearts exposed to 30-min WIT and Cs solution displayed complete recovery, while hearts exposed to 40-min WIT and Cs solution demonstrated partial recovery. We conclude that DCD hearts flushed with C solution demonstrate complete recovery up to 20-min WIT after which there is rapid loss of viability. Cs extends the limit of WIT tolerability to 30 min. DCD hearts with ≤30-min WIT may be suitable for transplantati...Continue Reading
Myocardial edema: comparison of effects on filling volume and stiffness of the left ventricle in rats and pigs
50th anniversary historical article. Myocardial oxygen consumption: the quest for its determinants and some clinical fallout
Myocyte and endothelial effects of preconditioning the jeopardized heart by inhibiting Na/H exchange
Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning
The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning
Improved preservation of the rat heart with celsior solution supplemented with cariporide plus glyceryl trinitrate
Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta
Resuscitation of non-beating donor hearts using continuous myocardial perfusion: the importance of controlled initial reperfusion
Circulatory load during hypoxia impairs post-transplant myocardial functional recovery in donation after cardiac death
Cardiac recovery in a human non-heart-beating donor after extracorporeal perfusion: source for human heart donation?
Combining cariporide with glyceryl trinitrate optimizes cardiac preservation during porcine heart transplantation
The potential of cardiac allografts from donors after cardiac death at the University of Wisconsin Organ Procurement Organization
Critical role of the STAT3 pathway in the cardioprotective efficacy of zoniporide in a model of myocardial preservation - the rat isolated working heart
Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis
A comprehensive risk assessment of mortality following donation after cardiac death liver transplant - an analysis of the national registry
Hearts from DCD donors display acceptable biventricular function after heart transplantation in pigs
Excellent clinical outcomes from a national donation-after-determination-of-cardiac-death lung transplant collaborative
Protection of pharmacological postconditioning in liver surgery: results of a prospective randomized controlled trial
Enhanced preservation of pig cardiac allografts by combining erythropoietin with glyceryl trinitrate and zoniporide
Enhanced preservation of the rat heart after prolonged hypothermic ischemia with erythropoietin-supplemented Celsior solution
Avoidance of Profound Hypothermia During Initial Reperfusion Improves the Functional Recovery of Hearts Donated After Circulatory Death
Moderate hypothermia during ex vivo machine perfusion promotes recovery of hearts donated after cardiocirculatory death†
Physiologic Changes in the Heart Following Cessation of Mechanical Ventilation in a Porcine Model of Donation After Circulatory Death: Implications for Cardiac Transplantation
Normothermic ex vivo perfusion provides superior organ preservation and enables viability assessment of hearts from DCD donors
Cardio-protective signalling by glyceryl trinitrate and cariporide in a model of donor heart preservation
A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion
Cardioprotective reperfusion strategies differentially affect mitochondria: Studies in an isolated rat heart model of donation after circulatory death (DCD)
New Strategies to Expand and Optimize Heart Donor Pool: Ex Vivo Heart Perfusion and Donation After Circulatory Death: A Review of Current Research and Future Trends
Paediatric donation after circulatory determined death heart transplantation using donor normothermic regional perfusion and ex situ heart perfusion: A case report
Ice, ice, maybe? Is it time to ditch the igloo cooler? Benefits of machine perfusion preservation of donor hearts
Pathophysiological Trends During Withdrawal of Life Support: Implications for Organ Donation After Circulatory Death
Comparing Donor Heart Assessment Strategies During Ex Situ Heart Perfusion to Better Estimate Post-Transplant Cardiac Function.
Enhanced myocardial protection in cardiac donation after circulatory death using Intralipid® postconditioning in a porcine model
Comparing Donor Heart Assessment Strategies During Ex Situ Heart Perfusion to Better Estimate Posttransplant Cardiac Function.
Hearts Donated After Circulatory Death and Reconditioned Using Normothermic Regional Perfusion Can Be Successfully Transplanted Following an Extended Period of Static Storage
Controlled Reperfusion Strategies Improve Cardiac Hemodynamic Recovery after Warm Global Ischemia in an Isolated, Working Rat Heart Model of Donation after Circulatory Death (DCD)
History of heart transplantation, the resurgence of DCD heart donations and outcomes following transplantation; the Royal Papworth Experience
Ischemia and reperfusion injury to mitochondria and cardiac function in donation after circulatory death hearts- an experimental study
Comparison of Experimental Rat Models in Donation After Circulatory Death (DCD): in-situ vs. ex-situ Ischemia.
Expanding controlled donation after the circulatory determination of death: statement from an international collaborative.
The Effect of Increasing Donor Age on Myocardial Ischemic Tolerance in a Rodent Model of Donation After Circulatory Death.
Ex Situ Perfusion of Hearts Donated After Euthanasia: A Promising Contribution to Heart Transplantation.
Therapeutic Inhibition of Acid Sensing Ion Channel 1a Recovers Heart Function After Ischemia-Reperfusion Injury.
Reconditioning of circulatory death hearts by ex-vivo machine perfusion with a novel HTK-N preservation solution.
Antianginal Drugs: Mechanisms of Action
Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.
Allogenic & Autologous Therapies
Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.